Switchback from Biosimilar to Biologic Rare Among Veteran Patients
Very few patients switch off a biosimilar due to adverse effects, according to a new study.
Kellym Bryan Veterans Affairs International Conference On Pharmacoepidemiology Medication Center Veterans Affairs Va Center International Conference
Source: hcplive.com